<html>
<head>PUBMED IDs for LZTR1</head>
<body bgcolor='#C5F0F2'><h1>LZTR1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22926078/'>Role of SNAP29, LZTR1 and P2RXL1 genes on immune regulation in a patient with atypical 0.5 Mb deletion in 22q11.2 region.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23917401/'>The integrated landscape of driver genomic alterations in glioblastoma.</a> November 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24362817/'>Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.</a> March 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25335493/'>Expanding the mutational spectrum of LZTR1 in schwannomatosis.</a> April 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25335492/'>Clinical utility gene card for: Abetalipoproteinaemia--Update 2014.</a> February 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25480913/'>Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.</a> April 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25795793/'>Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.</a> February 26  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25961944/'>Excess of rare, inherited truncating mutations in autism.</a> August 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26446362/'>Recent advances in RASopathies.</a> December 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26706012/'>Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26799435/'>Type 1 papillary renal cell carcinoma in a patient with schwannomatosis: Mosaic versus loss of SMARCB1 expression in respectively schwannoma and renal tumor cells.</a> September 27  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27421984/'>[Pathogenesis and molecular pathology of vestibular schwannoma].</a> July 17  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27921248/'>The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.</a> December 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27921232/'>Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.</a> December 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27958595/'>Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.</a> December 14  2016<br></body></html>
